Caco	O
-	O
2	O
Cell	O
Acquisition	O
of	O
Dietary	O
Iron	O
(	O
III	O
)	O
Invokes	O
a	O
Nanoparticulate	O
Endocytic	O
Pathway	O

Competing	O
Interests	O
:	O
The	O
authors	O
declare	O
no	O
conflict	O
of	O
interest	O
but	O
D	O
.	O
I	O
.	O
A	O
.	O
P	O
.,	O
N	O
.	O
F	O
.,	O
S	O
.	O
F	O
.	O
A	O
.	O
B	O
.	O
and	O
J	O
.	O
J	O
.	O
P	O
.	O
wish	O
to	O
note	O
that	O
they	O
are	O
inventors	O
on	O
a	O
patent	O
detailing	O
novel	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
structures	O
that	O
may	O
have	O
potential	O
as	O
dietary	O
supplements	O
[	O
Powell	O
,	O
J	O
.,	O
S	O
.	O

Bruggraber	O
,	O
et	O
al	O
.	O
(	O
2008	O
).	O

Ligand	O
modified	O
poly	O
oxo	O
-	O
hydroxy	O
metal	O
ion	O
materials	O
,	O
their	O
uses	O
and	O
processes	O
for	O
their	O
preparation	O
.	O

W	O
.	O

I	O
.	O

P	O
.	O

Organization	O
,	O
U	O
.	O
K	O
.	O

WO	O
/	O
2008	O
/	O
096130	O
].	O

This	O
patent	O
does	O
not	O
alter	O
adherence	O
to	O
all	O
PLOS	O
ONE	O
policies	O
on	O
sharing	O
data	O
or	O
materials	O
.	O

Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
DIAP	O
BIM	O
JJP	O
.	O

Performed	O
the	O
experiments	O
:	O
DIAP	O
BIM	O
LKP	O
LP	O
MFA	O
.	O

Analyzed	O
the	O
data	O
:	O
DIAP	O
BIM	O
MFA	O
APB	O
.	O

Contributed	O
reagents	O
/	O
materials	O
/	O
analysis	O
tools	O
:	O
BL	O
NF	O
SFAB	O
APB	O
.	O

Wrote	O
the	O
manuscript	O
:	O
DIAP	O
APB	O
JJP	O
.	O

Developed	O
the	O
hypothesis	O
behind	O
this	O
research	O
:	O
JJP	O
DIAP	O
.	O

Provided	O
input	O
on	O
development	O
of	O
the	O
hypothesis	O
behind	O
this	O
research	O
:	O
SFAB	O
NF	O
APB	O
.	O

Had	O
primary	O
responsibility	O
for	O
final	O
content	O
:	O
DIAP	O
JJP	O
.	O

Read	O
,	O
provided	O
input	O
to	O
and	O
approved	O
the	O
manuscript	O
:	O
DIAP	O
BIM	O
NF	O
SFAB	O
MFA	O
LKP	O
LP	O
BL	O
APB	O
JJP	O
.	O

These	O
authors	O
contribute	O
equally	O
to	O
this	O
work	O
.	O

Dietary	O
non	O
-	O
heme	O
iron	O
contains	O
ferrous	O
[	O
Fe	O
(	O
II	O
)]	O
and	O
ferric	O
[	O
Fe	O
(	O
III	O
)]	O
iron	O
fractions	O
and	O
the	O
latter	O
should	O
hydrolyze	O
,	O
forming	O
Fe	O
(	O
III	O
)	O
oxo	O
-	O
hydroxide	O
particles	O
,	O
on	O
passing	O
from	O
the	O
acidic	O
stomach	O
to	O
less	O
acidic	O
duodenum	O
.	O

Using	O
conditions	O
to	O
mimic	O
the	O
in	O
vivo	O
hydrolytic	O
environment	O
we	O
confirmed	O
the	O
formation	O
of	O
nanodisperse	O
fine	O
ferrihydrite	O
-	O
like	O
particles	O
.	O

Synthetic	O
analogues	O
of	O
these	O
(~	O
10	O
nm	O
hydrodynamic	O
diameter	O
)	O
were	O
readily	O
adherent	O
to	O
the	O
cell	O
membrane	O
of	O
differentiated	O
Caco	O
-	O
2	O
cells	O
and	O
internalization	O
was	O
visualized	O
using	O
transmission	O
electron	O
microscopy	O
.	O

Moreover	O
,	O
Caco	O
-	O
2	O
exposure	O
to	O
these	O
nanoparticles	O
led	O
to	O
ferritin	B-GP
formation	O
(	O
i	O
.	O
e	O
.,	O
iron	O
utilization	O
)	O
by	O
the	O
cells	O
,	O
which	O
,	O
unlike	O
for	O
soluble	O
forms	O
of	O
iron	O
,	O
was	O
reduced	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
by	O
inhibition	O
of	O
clathrin	B-GP
-	O
mediated	O
endocytosis	O
.	O

Simulated	O
lysosomal	O
digestion	O
indicated	O
that	O
the	O
nanoparticles	O
are	O
readily	O
dissolved	O
under	O
mildly	O
acidic	O
conditions	O
with	O
the	O
lysosomal	O
ligand	O
,	O
citrate	O
.	O

This	O
was	O
confirmed	O
in	O
cell	O
culture	O
as	O
monensin	O
inhibited	O
Caco	O
-	O
2	O
utilization	O
of	O
iron	O
from	O
this	O
source	O
in	O
a	O
dose	O
dependent	O
fashion	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
whilet	O
soluble	O
iron	O
was	O
again	O
unaffected	O
.	O

Our	O
findings	O
reveal	O
the	O
possibility	O
of	O
an	O
endocytic	O
pathway	O
for	O
acquisition	O
of	O
dietary	O
Fe	O
(	O
III	O
)	O
by	O
the	O
small	O
intestinal	O
epithelium	O
,	O
which	O
would	O
complement	O
the	O
established	O
DMT	B-GP
-	I-GP
1	I-GP
pathway	O
for	O
soluble	O
Fe	O
(	O
II	O
).	O

Introduction	O

Dietary	O
non	O
-	O
heme	O
iron	O
(	O
Fe	O
)	O
contains	O
ferrous	O
[	O
Fe	O
(	O
II	O
)]	O
and	O
ferric	O
[	O
Fe	O
(	O
III	O
)]	O
fractions	O
in	O
a	O
number	O
of	O
chemical	O
forms	O
:	O
for	O
example	O
Fe	O
in	O
ferritin	B-GP
and	O
in	O
Fe	B-GP
-	I-GP
sulphur	I-GP
cluster	I-GP
proteins	I-GP
[	O
1	O
–	O
3	O
].	O

Redox	O
changes	O
to	O
dietary	O
Fe	O
between	O
the	O
points	O
of	O
ingestion	O
and	O
cellular	O
uptake	O
from	O
the	O
intestinal	O
lumen	O
are	O
complex	O
and	O
may	O
favour	O
oxidation	O
to	O
Fe	O
(	O
III	O
)	O
due	O
to	O
intestinal	O
pH	O
and	O
endogenous	O
ligands	O
,	O
or	O
reduction	O
to	O
Fe	O
(	O
II	O
)	O
due	O
to	O
the	O
presence	O
of	O
ascorbate	O
and	O
low	O
luminal	O
oxygen	O
levels	O
[	O
4	O
,	O
5	O
].	O

Overall	O
,	O
however	O
,	O
both	O
Fe	O
(	O
II	O
)	O
and	O
Fe	O
(	O
III	O
)	O
appear	O
to	O
reach	O
the	O
intestinal	O
epithelial	O
surface	O
to	O
some	O
extent	O
[	O
4	O
,	O
6	O
–	O
8	O
].	O

Fe	O
(	O
II	O
)	O
is	O
transported	O
by	O
the	O
divalent	B-GP
metal	I-GP
transporter	I-GP
-	I-GP
1	I-GP
(	O
DMT	B-GP
-	I-GP
1	I-GP
)	O
and	O
Fe	O
(	O
III	O
)	O
is	O
proposed	O
to	O
undergo	O
enzymatic	O
reduction	O
to	O
Fe	O
(	O
II	O
),	O
perhaps	O
by	O
duodenal	B-GP
cytochrome	I-GP
B	I-GP
(	O
DcytB	B-GP
),	O
prior	O
to	O
transport	O
by	O
DMT	B-GP
-	I-GP
1	I-GP
[	O
9	O
–	O
13	O
].	O

Chemically	O
,	O
however	O
,	O
there	O
is	O
an	O
uncomfortable	O
paradox	O
with	O
respect	O
to	O
this	O
latter	O
pathway	O
.	O

Fe	O
(	O
III	O
)	O
is	O
remarkably	O
insoluble	O
at	O
duodenal	O
pH	O
,	O
immediately	O
precipitating	O
out	O
of	O
solution	O
as	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
:	O

[	O
logKeq	O
Fe3	O
+	O
+	O
3	O
H2O	O
↔	O
Fe	O
(	O
OH	O
)	O
3	O
+	O
3H	O
+	O
=	O
-	O
11	O
.	O
7	O
[	O
14	O
]].	O

To	O
obviate	O
iron	O
precipitation	O
several	O
authors	O
have	O
suggested	O
the	O
presence	O
of	O
endogenous	O
Fe	O
binding	O
agents	O
(	O
i	O
.	O
e	O
.	O
proteins	O
,	O
organic	O
acids	O
etc	O
.)	O
in	O
gastrointestinal	O
secretions	O
that	O
retain	O
Fe	O
(	O
III	O
)	O
in	O
a	O
soluble	O
form	O
.	O

The	O
aluminium	O
ion	O
(	O
Al	O
(	O
III	O
))	O
can	O
be	O
viewed	O
as	O
a	O
kinetically	O
less	O
labile	O
,	O
non	O
-	O
paramagnetic	O
metal	O
ion	O
(	O
M	O
)	O
‘	O
probe	O
’	O
for	O
Fe	O
(	O
III	O
).	O

Work	O
on	O
the	O
chemical	O
speciation	O
of	O
Al	O
(	O
III	O
)	O
in	O
the	O
intestinal	O
lumen	O
did	O
not	O
identify	O
any	O
endogenous	O
ligands	O
that	O
could	O
prevent	O
its	O
precipitation	O
as	O
an	O
oxo	O
-	O
hydroxide	O
at	O
peri	O
-	O
neutral	O
pH	O
[	O
15	O
].	O

Instead	O
,	O
Powell	O
et	O
al	O
.	O
proposed	O
that	O
a	O
range	O
of	O
endogenous	O
,	O
low	O
molecular	O
weight	O
ligands	O
could	O
slow	O
the	O
rate	O
of	O
hydrolysis	O
to	O
allow	O
M	O
(	O
III	O
)	O
binding	O
to	O
gastrointestinal	O
mucins	B-GP
[	O
15	O
].	O

Indeed	O
,	O
luminal	O
Fe	O
binding	O
to	O
gastrointestinal	O
mucins	B-GP
has	O
been	O
identified	O
by	O
a	O
number	O
of	O
authors	O
[	O
8	O
,	O
16	O
,	O
17	O
]	O
and	O
so	O
effective	O
is	O
this	O
binding	O
that	O
gastric	B-GP
mucin	I-GP
has	O
been	O
previously	O
referred	O
to	O
as	O
‘	O
gastroferrin	B-GP
’:	O
the	O
endogenous	O
gastro	O
(	O
intestinal	O
)	O
molecule	O
that	O
can	O
keep	O
dietary	O
Fe	O
(	O
III	O
)	O
in	O
‘	O
solution	O
’	O
[	O
18	O
–	O
24	O
].	O

Rudzki	O
et	O
al	O
.	O
detailed	O
the	O
nature	O
of	O
the	O
binding	O
between	O
Fe	O
(	O
III	O
)	O
and	O
the	O
Fe	B-GP
-	I-GP
binding	I-GP
glycoprotein	I-GP
of	O
gastric	O
juice	O
(	O
mucin	B-GP
)	O
and	O
showed	O
that	O
at	O
pH	O
values	O
of	O
the	O
proximal	O
bowel	O
(	O
typical	O
pH	O
range	O
5	O
.	O
8	O
-	O
6	O
.	O
7	O
[	O
25	O
]),	O
Fe	O
(	O
III	O
)	O
is	O
not	O
quite	O
kept	O
in	O
‘	O
solution	O
’	O
[	O
26	O
].	O
Instead	O
,	O
it	O
appears	O
that	O
Fe	O
(	O
III	O
)	O
commences	O
hydrolysis	O
but	O
further	O
growth	O
and	O
agglomeration	O
of	O
the	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
are	O
prevented	O
by	O
mucin	B-GP
binding	O
[	O
26	O
].	O

They	O
visualized	O
the	O
nanoparticles	O
formed	O
in	O
the	O
Fe	O
-	O
glycoprotein	O
complex	O
,	O
noting	O
that	O
they	O
were	O
~	O
10	O
-	O
20	O
nm	O
in	O
diameter	O
and	O
appeared	O
to	O
be	O
amorphous	O
aggregates	O
.	O

The	O
Fe	O
(	O
III	O
)	O
oxo	O
-	O
hydroxide	O
phase	O
expected	O
to	O
first	O
precipitate	O
from	O
an	O
Fe	O
(	O
III	O
)-	O
bearing	O
solution	O
at	O
proximal	O
small	O
bowel	O
pH	O
is	O
ferrihydrite	O
[	O
27	O
].	O

This	O
is	O
a	O
cross	O
-	O
linked	O
polymeric	O
(	O
i	O
.	O
e	O
.	O
poorly	O
(	O
nano	O
)	O
crystalline	O
)	O
phase	O
with	O
primary	O
platelets	O
of	O
2	O
-	O
5	O
nm	O
in	O
size	O
depending	O
on	O
the	O
degree	O
of	O
crystallinity	O
and	O
is	O
prone	O
to	O
agglomeration	O
and	O
aggregation	O
[	O
28	O
].	O

Rudzki	O
et	O
al	O
.	O
produced	O
a	O
synthetic	O
version	O
,	O
referring	O
to	O
this	O
phase	O
as	O
colloidal	O
Fe	O
and	O
,	O
importantly	O
,	O
showed	O
that	O
direct	O
instillation	O
of	O
this	O
ferrihydrite	O
–	O
mucin	B-GP
solution	O
into	O
the	O
duodenum	O
of	O
rats	B-OG
,	O
led	O
to	O
Fe	O
absorption	O
nearly	O
equivalent	O
to	O
that	O
of	O
the	O
gold	O
standard	O
,	O
Fe	O
(	O
II	O
)	O
ascorbate	O
[	O
26	O
].	O

How	O
nanoparticulate	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
,	O
which	O
is	O
insoluble	O
at	O
duodenal	O
pH	O
,	O
would	O
be	O
acquired	O
by	O
enterocytes	O
and	O
processed	O
for	O
absorption	O
and	O
utilization	O
is	O
not	O
clear	O
.	O

Current	O
understanding	O
of	O
dietary	O
Fe	O
(	O
III	O
)	O
absorption	O
suggests	O
synergistic	O
association	O
between	O
an	O
intestinal	O
ferrireductase	B-GP
(	O
e	O
.	O
g	O
.	O
DcytB	B-GP
)	O
and	O
the	O
apical	O
Fe	B-GP
(	I-GP
II	I-GP
)	I-GP
transporter	I-GP
(	O
DMT	B-GP
-	I-GP
1	I-GP
)	O
such	O
that	O
the	O
enzyme	O
reduces	O
Fe	O
(	O
III	O
)	O
allowing	O
its	O
transport	O
and	O
absorption	O
.	O

However	O
,	O
our	O
current	O
in	O
vivo	O
studies	O
reasonably	O
preclude	O
the	O
requirement	O
for	O
reduction	O
and	O
dissolution	O
of	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
prior	O
to	O
uptake	O
by	O
the	O
enterocyte	O
(	O
Pereira	O
,	O
Latunde	O
-	O
Dada	O
and	O
Powell	O
;	O
unpublished	O
observations	O
).	O

To	O
investigate	O
the	O
above	O
paradox	O
in	O
more	O
detail	O
we	O
first	O
built	O
on	O
the	O
model	O
of	O
Rudzki	O
et	O
al	O
.	O
[	O
26	O
,	O
29	O
]	O
using	O
mucin	B-GP
plus	O
typical	O
low	O
molecular	O
weight	O
ligands	O
of	O
the	O
gastrointestinal	O
lumen	O
to	O
better	O
mimic	O
in	O
vivo	O
Fe	O
(	O
III	O
)	O
hydrolysis	O
.	O

We	O
confirmed	O
the	O
formation	O
of	O
a	O
fine	O
ferrihydrite	O
-	O
like	O
phase	O
in	O
‘	O
luminally	O
hydrolysed	O
’	O
dietary	O
Fe	O
(	O
III	O
)	O
and	O
then	O
we	O
probed	O
cellular	O
uptake	O
and	O
utilization	O
of	O
synthetic	O
ligand	O
-	O
modified	O
ferrihydrite	O
,	O
as	O
an	O
analogue	O
for	O
this	O
nanoparticulate	O
phase	O
,	O
demonstrating	O
the	O
requirement	O
of	O
endocytic	O
uptake	O
mechanisms	O
.	O

Materials	O
and	O
Methods	O

Synthesis	O
of	O
iron	O
materials	O

Soluble	O
Fe	O
(	O
II	O
)	O
material	O
was	O
prepared	O
by	O
mixing	O
an	O
acidified	O
stock	O
solution	O
of	O
Fe	O
(	O
II	O
)	O
sulphate	O
heptahydrate	O
(	O
40	O
mM	O
)	O
with	O
a	O
stock	O
solution	O
of	O
ascorbic	O
acid	O
(	O
0	O
.	O
5	O
M	O
)	O
to	O
achieve	O
a	O
molar	O
ratio	O
of	O
1	O
:	O
100	O
(	O
Fe	O
:	O
ascorbic	O
acid	O
).	O

Soluble	O
Fe	O
(	O
III	O
)	O
maltol	O
chelate	O
(	O
Fe	O
(	O
III	O
)	O
maltol	O
)	O
was	O
produced	O
by	O
mixing	O
a	O
stock	O
solution	O
of	O
Fe	O
(	O
III	O
)	O
chloride	O
(	O
8	O
mM	O
)	O
with	O
a	O
maltol	O
(	O
3	O
-	O
hydroxy	O
-	O
2	O
-	O
methyl	O
-	O
4H	O
-	O
pyran	O
-	O
4	O
-	O
one	O
)	O
solution	O
(	O
40	O
mM	O
)	O
to	O
achieve	O
a	O
molar	O
ratio	O
of	O
Fe	O
:	O
maltol	O
of	O
1	O
:	O
5	O
.	O

Soluble	O
Fe	O
(	O
III	O
)	O
nitrilotriacetate	O
chelate	O
(	O
Fe	O
(	O
III	O
)	O
NTA	O
)	O
was	O
produced	O
by	O
mixing	O
a	O
solution	O
of	O
Fe	O
(	O
III	O
)	O
chloride	O
(	O
8	O
mM	O
)	O
with	O
a	O
NTA	O
solution	O
to	O
achieve	O
a	O
molar	O
ratio	O
of	O
Fe	O
:	O
NTA	O
of	O
1	O
:	O
5	O
.	O

The	O
pH	O
of	O
the	O
above	O
mixtures	O
was	O
adjusted	O
to	O
7	O
.	O
4	O
with	O
NaOH	O
prior	O
to	O
use	O
.	O

Ligand	O
-	O
modified	O
(	O
LM	O
)	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
material	O
was	O
produced	O
following	O
the	O
protocol	O
described	O
by	O
Powell	O
et	O
al	O
.	O
[	O
30	O
].	O

Briefly	O
,	O
an	O
acidic	O
concentrated	O
stock	O
solution	O
of	O
Fe	O
(	O
III	O
)	O
chloride	O
(	O
40	O
mM	O
)	O
was	O
added	O
to	O
a	O
solution	O
containing	O
tartaric	O
acid	O
and	O
adipic	O
acid	O
or	O
,	O
in	O
the	O
case	O
of	O
un	O
-	O
modified	O
Fe	O
(	O
III	O
)	O
oxo	O
-	O
hydroxide	O
,	O
to	O
0	O
.	O
9	O
%(	O
w	O
/	O
v	O
)	O
of	O
electrolyte	O
(	O
potassium	O
chloride	O
).	O

The	O
initial	O
pH	O
of	O
the	O
mixture	O
was	O
always	O
below	O
2	O
.	O
0	O
and	O
the	O
iron	O
was	O
fully	O
solubilized	O
.	O

The	O
pH	O
was	O
then	O
slowly	O
increased	O
by	O
drop	O
-	O
wise	O
addition	O
of	O
a	O
concentrated	O
solution	O
of	O
NaOH	O
with	O
constant	O
agitation	O
until	O
the	O
desired	O
final	O
pH	O
(	O
ca	O
.	O

7	O
.	O
4	O
for	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
and	O
7	O
.	O
4	O
-	O
8	O
.	O
2	O
for	O
un	O
-	O
modified	O
Fe	O
(	O
III	O
)	O
oxo	O
-	O
hydroxide	O
)	O
were	O
attained	O
.	O

In	O
the	O
case	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
the	O
ratio	O
of	O
Fe	O
:	O
tartaric	O
acid	O
:	O
adipic	O
acid	O
in	O
the	O
final	O
suspension	O
was	O
2	O
:	O
1	O
:	O
1	O
.	O

Chemical	O
characterisation	O

Detailed	O
methods	O
of	O
the	O
below	O
are	O
provided	O
in	O
the	O
Supplementary	O
Methods	O
S1	O
.	O

Fe	O
(	O
III	O
)	O
structures	O
were	O
characterised	O
by	O
transmission	O
electron	O
microscopy	O
(	O
TEM	O
)	O
after	O
hydrolysis	O
of	O
Fe	O
(	O
III	O
)	O
in	O
simulated	O
digestion	O
medium	O
.	O

The	O
solubility	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
and	O
un	O
-	O
modified	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
i	O
.	O
e	O
.	O
standard	O
synthetic	O
ferrihydrite	O
)	O
was	O
determined	O
at	O
pH	O
5	O
.	O
0	O
±	O
0	O
.	O
1	O
in	O
a	O
10	O
mM	O
citric	O
acid	O
,	O
0	O
.	O
15	O
M	O
NaCl	O
solution	O
.	O

The	O
Fe	O
material	O
was	O
added	O
to	O
the	O
assay	O
solution	O
at	O
an	O
Fe	O
concentration	O
of	O
ca	O
.	O

1	O
mM	O
and	O
incubated	O
for	O
360	O
min	O
at	O
room	O
temperature	O
.	O

Soluble	O
iron	O
was	O
determined	O
following	O
ultrafiltration	O
(	O
3	O
,	O
000	O
Da	O
MWCO	O
).	O

The	O
hydrodynamic	O
particle	O
size	O
of	O
the	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
material	O
was	O
determined	O
by	O
Dynamic	O
Light	O
Scattering	O
(	O
DLS	O
)	O
and	O
the	O
non	O
-	O
aquated	O
primary	O
particle	O
size	O
by	O
Transmission	O
Electron	O
Microscopy	O
(	O
TEM	O
).	O

Cellular	O
uptake	O
studies	O

To	O
avoid	O
aggregation	O
/	O
agglomeration	O
of	O
the	O
nanoparticulate	O
iron	O
,	O
the	O
medium	O
for	O
cellular	O
uptake	O
consisted	O
of	O
a	O
balanced	O
salt	O
solution	O
(	O
BSS	O
)	O
containing	O
130	O
mM	O
NaCl	O
,	O
10	O
mM	O
KCl	O
,	O
1	O
mM	O
MgSO4	O
,	O
5	O
mM	O
Glucose	O
and	O
1	O
mM	O
CaCl2	O
in	O
10	O
mM	O
PIPES	O
buffer	O
(	O
pH	O
7	O
.	O
4	O
).	O

Immediately	O
before	O
the	O
cellular	O
uptake	O
experiments	O
,	O
fresh	O
solutions	O
of	O
the	O
Fe	O
materials	O
were	O
prepared	O
in	O
BSS	O
at	O
an	O
Fe	O
concentration	O
of	O
200	O
μM	O
and	O
the	O
partition	O
of	O
the	O
Fe	O
into	O
the	O
soluble	O
,	O
nanoparticulate	O
and	O
microparticulate	O
fractions	O
was	O
assessed	O
to	O
assure	O
that	O
most	O
of	O
the	O
Fe	O
(	O
i	O
.	O
e	O
.	O
>	O
90	O
%)	O
was	O
present	O
in	O
the	O
nanoparticulate	O
fraction	O
and	O
had	O
not	O
agglomerated	O
/	O
aggregated	O
.	O

DLS	O
measurements	O
were	O
also	O
taken	O
of	O
the	O
nanoparticulate	O
fraction	O
to	O
assure	O
a	O
mono	O
-	O
disperse	O
distribution	O
of	O
the	O
intended	O
size	O
(	O
i	O
.	O
e	O
.	O
~	O
10nm	O
).	O

Detailed	O
methodology	O
is	O
shown	O
in	O
Methods	O
S1	O
.	O

Iron	O
uptake	O
in	O
undifferentiated	O
Caco	O
-	O
2	O
cells	O

Human	B-OG
adenocarcinoma	B-DS
(	O
Caco	O
-	O
2	O
)	O
cells	O
were	O
obtained	O
from	O
ATCC	O
(	O
LGC	O
standards	O
,	O
Middlesex	O
,	O
United	O
Kingdom	O
).	O

Cells	O
were	O
seeded	O
at	O
1	O
.	O
13	O
x	O
106	O
cells	O
/	O
mL	O
onto	O
6	O
-	O
well	O
cell	O
culture	O
plates	O
.	O

Plates	O
were	O
centrifuged	O
at	O
680	O
xg	O
for	O
5	O
min	O
to	O
remove	O
the	O
growth	O
medium	O
.	O

The	O
different	O
Fe	O
preparations	O
in	O
uptake	O
medium	O
were	O
carefully	O
added	O
to	O
the	O
cells	O
and	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
.	O

Uptake	O
medium	O
with	O
no	O
supplemented	O
Fe	O
was	O
also	O
incubated	O
with	O
cells	O
as	O
a	O
control	O
.	O

Each	O
condition	O
was	O
tested	O
in	O
triplicate	O
wells	O
for	O
each	O
experiment	O
.	O

After	O
the	O
Fe	O
incubation	O
period	O
,	O
the	O
uptake	O
medium	O
was	O
removed	O
by	O
centrifugation	O
and	O
aspiration	O
,	O
and	O
the	O
cells	O
were	O
washed	O
with	O
phosphate	O
buffered	O
saline	O
(	O
PBS	O
)-	O
EDTA	O
(	O
2	O
mM	O
)	O
to	O
remove	O
any	O
loosely	O
bound	O
Fe	O
.	O

The	O
cells	O
were	O
then	O
resuspended	O
in	O
fresh	O
MEM	O
(	O
with	O
no	O
supplemental	O
Fe	O
)	O
and	O
returned	O
to	O
the	O
incubator	O
for	O
an	O
additional	O
23	O
h	O
to	O
allow	O
for	O
ferritin	B-GP
-	O
protein	O
formation	O
to	O
plateau	O
[	O
31	O
].	O

At	O
the	O
end	O
of	O
the	O
incubation	O
period	O
,	O
the	O
cells	O
were	O
washed	O
with	O
Dulbecco	O
'	O
s	O
Phosphate	O
-	O
Buffered	O
Saline	O
(	O
DPBS	O
;	O
PAA	O
Laboratories	O
)	O
and	O
lysed	O
with	O
Mammalian	O
Protein	O
Extraction	O
Reagent	O
(	O
MPER	O
®,	O
Thermo	O
Fisher	O
Scientific	O
,	O
Cramlington	O
,	O
UK	O
).	O

After	O
lysis	O
,	O
cell	O
debris	O
was	O
removed	O
by	O
centrifugation	O
(	O
5	O
min	O
,	O
16	O
,	O
000	O
xg	O
)	O
and	O
the	O
supernatant	O
used	O
for	O
analysis	O
.	O

Iron	O
uptake	O
in	O
differentiated	O
Caco	O
-	O
2	O
cells	O

Cells	O
(	O
Caco	O
-	O
2	O
ATCC	O
as	O
above	O
)	O
were	O
seeded	O
at	O
ca	O
.	O

1	O
.	O
8	O
x	O
105	O
cells	O
/	O
mL	O
onto	O
6	O
-	O
well	O
cell	O
culture	O
plates	O
.	O

The	O
Caco	O
-	O
2	O
cells	O
were	O
maintained	O
under	O
the	O
culture	O
conditions	O
described	O
in	O
Methods	O
S1	O
and	O
used	O
for	O
the	O
Fe	O
uptake	O
experiments	O
at	O
11	O
or	O
12	O
days	O
post	O
-	O
seeding	O
.	O

Cell	O
differentiation	O
and	O
formation	O
of	O
a	O
cell	O
monolayer	O
were	O
confirmed	O
for	O
this	O
timepoint	O
as	O
described	O
in	O
Methods	O
S1	O
.	O

Approximately	O
16	O
h	O
prior	O
to	O
the	O
experiments	O
the	O
growth	O
medium	O
was	O
replaced	O
by	O
non	O
-	O
supplemented	O
MEM	O
,	O
i	O
.	O
e	O
.	O
without	O
FBS	O
or	O
antibiotics	O
,	O
and	O
cells	O
were	O
returned	O
to	O
the	O
incubator	O
.	O

This	O
was	O
carried	O
out	O
to	O
‘	O
starve	O
’	O
cells	O
of	O
Fe	O
prior	O
to	O
the	O
experiments	O
and	O
did	O
not	O
induce	O
any	O
changes	O
in	O
the	O
cell	O
monolayer	O
integrity	O
as	O
confirmed	O
by	O
TEER	O
measurements	O
.	O

The	O
Caco	O
-	O
2	O
cell	O
monolayer	O
was	O
then	O
washed	O
once	O
with	O
pre	O
-	O
warmed	O
DPBS	O
and	O
incubated	O
with	O
the	O
different	O
Fe	O
materials	O
or	O
control	O
uptake	O
medium	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
.	O

For	O
each	O
experiment	O
every	O
condition	O
was	O
investigated	O
in	O
triplicate	O
wells	O
.	O

Following	O
the	O
Fe	O
incubation	O
period	O
the	O
uptake	O
medium	O
was	O
removed	O
,	O
the	O
cell	O
monolayer	O
was	O
washed	O
three	O
times	O
with	O
PBS	O
-	O
EDTA	O
(	O
2	O
mM	O
)	O
to	O
remove	O
any	O
Fe	O
loosely	O
adherent	O
to	O
the	O
cell	O
membrane	O
and	O
fresh	O
non	O
-	O
supplemented	O
MEM	O
was	O
added	O
.	O

The	O
cells	O
were	O
then	O
returned	O
to	O
the	O
incubator	O
for	O
an	O
additional	O
23	O
h	O
to	O
allow	O
for	O
ferritin	B-GP
-	O
protein	O
formation	O
[	O
31	O
].	O

At	O
the	O
end	O
of	O
the	O
incubation	O
period	O
,	O
the	O
cells	O
were	O
washed	O
and	O
lysed	O
as	O
before	O
.	O

The	O
cell	O
lysate	O
supernatant	O
was	O
used	O
for	O
analysis	O
.	O

The	O
Caco	O
-	O
2	O
cells	O
requirement	O
of	O
energy	O
for	O
Fe	O
uptake	O
from	O
Fe	O
(	O
III	O
)	O
maltol	O
or	O
the	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
was	O
investigated	O
by	O
low	O
temperature	O
incubation	O
.	O

The	O
cells	O
were	O
kept	O
on	O
ice	O
for	O
10	O
min	O
prior	O
to	O
the	O
experiment	O
and	O
during	O
the	O
1	O
h	O
incubation	O
period	O
with	O
the	O
two	O
Fe	O
materials	O
suspended	O
in	O
uptake	O
medium	O
.	O

The	O
cells	O
were	O
then	O
washed	O
3	O
times	O
with	O
ice	O
-	O
cold	O
PBS	O
-	O
EDTA	O
(	O
2	O
mM	O
)	O
and	O
fresh	O
non	O
-	O
supplemented	O
MEM	O
was	O
added	O
and	O
the	O
cells	O
incubated	O
for	O
the	O
remaining	O
23	O
h	O
at	O
37	O
°	O
C	O
and	O
treated	O
as	O
above	O
.	O

To	O
study	O
the	O
effect	O
of	O
endocytosis	O
-	O
related	O
-	O
pathway	O
-	O
inhibitors	O
on	O
Fe	O
uptake	O
from	O
the	O
different	O
materials	O
,	O
Caco	O
-	O
2	O
cells	O
were	O
co	O
-	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
with	O
the	O
Fe	O
materials	O
in	O
BSS	O
supplemented	O
with	O
the	O
following	O
inhibitors	O
(	O
each	O
inhibitor	O
tested	O
in	O
triplicate	O
wells	O
):	O
chlorpromazine	O
(	O
100	O
µM	O
),	O
filipin	O
(	O
5	O
mg	O
/	O
L	O
),	O
methyl	O
-	O
β	O
-	O
cyclodextrin	O
(	O
5	O
mM	O
).	O

Additionally	O
,	O
cells	O
were	O
incubated	O
with	O
Fe	O
in	O
K	O
+-	O
free	O
BSS	O
consisting	O
of	O
130	O
mM	O
NaCl	O
,	O
1	O
mM	O
MgSO4	O
,	O
5	O
mM	O
glucose	O
and	O
1	O
mM	O
CaCl2	O
in	O
10	O
mM	O
PIPES	O
buffer	O
(	O
pH	O
7	O
.	O
4	O
).	O

For	O
this	O
experimental	O
condition	O
cells	O
were	O
pre	O
-	O
incubated	O
for	O
5	O
min	O
with	O
a	O
1	O
:	O
1	O
mixture	O
of	O
Dulbecco	O
'	O
s	O
Modified	O
Eagle	O
Medium	O
(	O
DMEM	O
):	O
water	O
prior	O
to	O
incubation	O
in	O
K	O
+-	O
free	O
medium	O
.	O

For	O
the	O
cellular	O
lysosomal	O
dissolution	O
experiments	O
,	O
cells	O
were	O
co	O
-	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
with	O
the	O
Fe	O
materials	O
in	O
BSS	O
supplemented	O
with	O
monensin	O
(	O
5	O
-	O
30	O
µM	O
).	O

As	O
before	O
ferritin	B-GP
-	O
formation	O
was	O
assessed	O
at	O
23h	O
following	O
the	O
removal	O
of	O
the	O
inhibitors	O
and	O
Fe	O
materials	O
.	O

Controls	O
were	O
performed	O
for	O
each	O
inhibitor	O
by	O
incubating	O
the	O
cells	O
with	O
uptake	O
medium	O
(	O
BSS	O
)	O
supplemented	O
with	O
the	O
inhibitor	O
but	O
not	O
containing	O
Fe	O
.	O

Chlorpromazine	O
[	O
32	O
,	O
33	O
]	O
and	O
K	O
+	O
free	O
BSS	O
[	O
33	O
,	O
34	O
]	O
were	O
used	O
to	O
inhibit	O
clathrin	B-GP
-	O
mediated	O
uptake	O
.	O

Filipin	O
[	O
35	O
]	O
and	O
methyl	O
-	O
β	O
-	O
cyclodextrin	O
[	O
34	O
,	O
36	O
]	O
were	O
used	O
to	O
inhibit	O
caveolin	B-GP
-	O
mediated	O
uptake	O
.	O

Monensin	O
was	O
used	O
to	O
inhibit	O
acidification	O
of	O
endosomes	O
/	O
lysosomes	O
[	O
37	O
–	O
39	O
].	O

Analysis	O

Cell	O
lysate	O
supernatants	O
were	O
analysed	O
for	O
cellular	O
ferritin	B-GP
-	O
protein	O
content	O
using	O
the	O
commercial	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
kit	O
“	O
Spectro	O
Ferritin	B-GP
”	O
(	O
ATI	O
Atlas	O
,	O
Chichester	O
,	O
UK	O
).	O

The	O
uptake	O
data	O
were	O
normalized	O
to	O
total	O
cell	O
protein	O
content	O
determined	O
with	O
the	O
non	O
-	O
interfering	O
protein	O
assay	O
™	O
(	O
NIPA	O
™,	O
Calbiochem	O
/	O
Merck	O
,	O
Nottingham	O
,	O
UK	O
).	O

TEER	O
measurements	O
were	O
carried	O
out	O
to	O
determine	O
if	O
the	O
chemical	O
inhibitors	O
used	O
in	O
the	O
uptake	O
studies	O
had	O
a	O
negative	O
impact	O
on	O
the	O
integrity	O
of	O
the	O
cell	O
monolayer	O
(	O
an	O
early	O
indication	O
of	O
toxicity	O
)	O
as	O
detailed	O
in	O
Methods	O
S1	O
.	O

Electron	O
microscopy	O
was	O
used	O
to	O
visualize	O
nanoparticulate	O
Fe	O
uptake	O
by	O
the	O
Caco	O
-	O
2	O
cells	O
as	O
detailed	O
in	O
Methods	O
S1	O
.	O

Statistical	O
analysis	O

All	O
statistical	O
analysis	O
was	O
performed	O
using	O
GraphPad	O
Prism	O
version	O
6	O
for	O
Windows	O
(	O
GraphPad	O
Software	O
,	O
San	O
Diego	O
,	O
California	O
,	O
USA	O
).	O

Unless	O
stated	O
otherwise	O
,	O
results	O
are	O
presented	O
as	O
means	O
with	O
standard	O
deviations	O
(	O
s	O
.	O
d	O
.).	O

The	O
unpaired	O
t	O
-	O
test	O
was	O
used	O
to	O
statistically	O
compare	O
ferritin	B-GP
-	O
protein	O
formation	O
for	O
the	O
different	O
Fe	O
compounds	O
in	O
differentiated	O
and	O
undifferentiated	O
cells	O
and	O
ferritin	B-GP
-	O
protein	O
formation	O
with	O
and	O
without	O
chemical	O
inhibitors	O
of	O
endocytosis	O
-	O
related	O
pathways	O
(	O
level	O
of	O
significance	O
set	O
to	O
p	O
<	O
0	O
.	O
05	O
).	O

The	O
repeated	O
measures	O
2	O
-	O
way	O
ANOVA	O
with	O
Sidak	O
correction	O
for	O
multiple	O
comparisons	O
was	O
used	O
to	O
statistically	O
compare	O
TEER	O
at	O
different	O
time	O
points	O
.	O

Regular	O
2	O
-	O
way	O
ANOVA	O
(	O
no	O
matching	O
)	O
was	O
used	O
to	O
statistically	O
compare	O
ferritin	B-GP
formation	O
for	O
different	O
monensin	O
doses	O
between	O
the	O
nano	O
Fe	O
and	O
the	O
soluble	O
Fe	O
materials	O
.	O

Ferritin	B-GP
-	O
protein	O
concentration	O
in	O
the	O
presence	O
of	O
monensin	O
was	O
fitted	O
with	O
a	O
non	O
-	O
linear	O
dose	O
-	O
response	O
inhibition	O
curve	O
(	O
i	O
.	O
e	O
.	O
Log10	O
(	O
inhibitor	O
)	O
versus	O
response	O
).	O

Results	O
and	O
Discussion	O

Formation	O
and	O
cellular	O
uptake	O
of	O
ligand	O
-	O
modified	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O

First	O
,	O
as	O
a	O
mimetic	O
of	O
gastrointestinal	O
hydrolysis	O
conditions	O
,	O
Fe	O
(	O
III	O
)	O
chloride	O
was	O
dissolved	O
at	O
pH	O
1	O
.	O
2	O
in	O
a	O
solution	O
of	O
relevant	O
,	O
low	O
molecular	O
weight	O
ligands	O
and	O
gastric	O
porcine	B-OG
mucin	B-GP
and	O
then	O
adjusted	O
to	O
pH	O
6	O
.	O
5	O
-	O
7	O
.	O
1	O
using	O
sodium	O
bicarbonate	O
(	O
final	O
Fe	O
concentration	O
1	O
mM	O
)	O
(	O
detailed	O
methodology	O
is	O
available	O
in	O
Methods	O
S1	O
).	O

A	O
drop	O
of	O
the	O
resultant	O
‘	O
solution	O
’	O
(	O
colloidal	O
suspension	O
)	O
was	O
placed	O
on	O
a	O
thin	O
amorphous	O
carbon	O
film	O
for	O
TEM	O
and	O
imaged	O
.	O

Agglomerates	O
of	O
fine	O
(~	O
5	O
nm	O
)	O
poorly	O
crystalline	O
particles	O
in	O
an	O
amorphous	O
gel	O
were	O
noted	O
(	O
Figure	O
1A	O
).	O

Whole	O
area	O
energy	O
dispersive	O
X	O
-	O
ray	O
spectroscopy	O
(	O
EDX	O
)	O
showed	O
these	O
to	O
be	O
Fe	O
-	O
containing	O
(	O
Figure	O
1B	O
),	O
and	O
electron	O
diffraction	O
(	O
not	O
shown	O
)	O
indicated	O
a	O
mixture	O
of	O
two	O
phases	O
–	O
ferrihydrite	O
-	O
like	O
(	O
two	O
broad	O
diffraction	O
rings	O
characteristic	O
of	O
2	O
-	O
line	O
ferrihydrite	O
[	O
40	O
])	O
and	O
a	O
second	O
phase	O
which	O
was	O
not	O
uniquely	O
identified	O
(	O
two	O
broad	O
diffraction	O
rings	O
at	O
0	O
.	O
20	O
and	O
0	O
.	O
13	O
nm	O
).	O

Under	O
prolonged	O
exposure	O
to	O
the	O
electron	O
beam	O
the	O
particles	O
agglomerated	O
further	O
,	O
developed	O
in	O
crystallinity	O
and	O
the	O
diffraction	O
pattern	O
became	O
dominated	O
by	O
this	O
second	O
phase	O
:	O
it	O
was	O
still	O
not	O
possible	O
to	O
confirm	O
the	O
identity	O
of	O
this	O
alteration	O
product	O
but	O
an	O
Fe	O
phosphate	O
hydroxide	O
provides	O
the	O
closest	O
match	O
to	O
the	O
observed	O
lattice	O
spacings	O
(	O
International	O
Centre	O
for	O
Diffraction	O
Data	O
powder	O
diffraction	O
file	O
00	O
-	O
047	O
-	O
0413	O
).	O

Irradiation	O
damage	O
to	O
poorly	O
crystalline	O
fine	O
particles	O
such	O
as	O
ferrihydrite	O
[	O
41	O
]	O
is	O
well	O
recognized	O
,	O
especially	O
in	O
the	O
absence	O
of	O
supporting	O
resin	O
or	O
tissue	O
structure	O
,	O
so	O
we	O
considered	O
this	O
second	O
phase	O
to	O
be	O
artifactual	O
.	O

Hence	O
the	O
larger	O
particles	O
(	O
10	O
-	O
20	O
nm	O
)	O
observed	O
in	O
the	O
earlier	O
work	O
of	O
Rudzki	O
et	O
al	O
.	O
[	O
26	O
]	O
are	O
,	O
likely	O
,	O
an	O
artifact	O
of	O
beam	O
damage	O
but	O
the	O
smaller	O
particles	O
are	O
not	O
.	O

Moreover	O
,	O
the	O
hydrolysis	O
of	O
the	O
Fe	O
(	O
III	O
)	O
and	O
the	O
formation	O
of	O
these	O
fine	O
,	O
disperse	O
,	O
ferrihydrite	O
-	O
like	O
particles	O
was	O
not	O
prevented	O
by	O
the	O
presence	O
of	O
typical	O
gastrointestinal	O
low	O
-	O
molecular	O
weight	O
ligands	O
.	O

As	O
a	O
simplified	O
and	O
practical	O
analogue	O
to	O
the	O
above	O
ferrihydrite	O
-	O
like	O
particles	O
we	O
have	O
developed	O
ligand	O
-	O
modified	O
(	O
LM	O
)	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxides	O
of	O
similar	O
size	O
and	O
structure	O
[	O
30	O
].	O

This	O
ligand	O
-	O
modified	O
analogue	O
remains	O
well	O
-	O
dispersed	O
upon	O
aqueous	O
suspension	O
in	O
the	O
uptake	O
medium	O
used	O
for	O
cellular	O
experiments	O
(	O
balanced	O
salt	O
solution	O
:	O
BSS	O
)	O
taking	O
on	O
an	O
average	O
hydrodynamic	O
particle	O
diameter	O
of	O
10	O
nm	O
(	O
Figure	O
1C	O
).	O

Characterisation	O
of	O
hydrolysed	O
Fe	O
(	O
III	O
)	O
with	O
simulated	O
digestion	O
and	O
of	O
aquated	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
.	O

A	O
,	O
Transmission	O
Electron	O
Microscopy	O
(	O
TEM	O
)	O
images	O
collected	O
from	O
a	O
drop	O
of	O
suspension	O
after	O
simulated	O
digestion	O
of	O
1	O
mM	O
Fe	O
(	O
III	O
)	O
chloride	O
in	O
the	O
presence	O
of	O
2	O
g	O
/	O
L	O
mucin	B-GP
and	O
low	O
molecular	O
weight	O
ligands	O
.	O

The	O
boxed	O
regions	O
are	O
shown	O
magnified	O
below	O
and	O
highlight	O
the	O
presence	O
of	O
fine	O
,	O
poorly	O
crystalline	O
nanoparticles	O
dispersed	O
in	O
an	O
amorphous	O
gel	O
.	O

Crystallinity	O
is	O
indicated	O
by	O
the	O
spots	O
in	O
the	O
inset	O
diffractograms	O
(	O
fast	O
Fourier	O
transforms	O
)	O
in	O
the	O
boxed	O
regions	O
and	O
lattice	O
spacings	O
are	O
discussed	O
in	O
the	O
main	O
text	O
.	O

Scale	O
bar	O
represents	O
5	O
nm	O
.	O
B	O
,	O
Whole	O
area	O
EDX	O
analysis	O
of	O
a	O
particle	O
agglomerate	O
similar	O
to	O
those	O
in	O
‘	O
A	O
’	O
shows	O
elemental	O
compositions	O
(	O
the	O
specimen	O
support	O
film	O
and	O
grid	O
produce	O
the	O
background	O
C	O
and	O
Cu	O
signals	O
respectively	O
).	O
C	O
,	O
Hydrodynamic	O
size	O
distribution	O
of	O
nanoparticulate	O
500	O
µM	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
in	O
balanced	O
salt	O
solution	O
(	O
BSS	O
)	O
measured	O
by	O
Dynamic	O
Light	O
Scattering	O
(	O
DLS	O
).	O

Values	O
are	O
expressed	O
as	O
mean	O
diameter	O
±	O
s	O
.	O
d	O
.	O

(	O
3	O
independent	O
measurements	O
)	O
on	O
a	O
log10	O
scale	O
.	O

Here	O
,	O
ferritin	B-GP
-	O
protein	O
formation	O
of	O
epithelial	O
cell	O
cultures	O
,	O
as	O
a	O
measure	O
of	O
cellular	O
iron	O
utilisation	O
,	O
was	O
assessed	O
following	O
a	O
24	O
h	O
total	O
incubation	O
period	O
that	O
involved	O
1	O
h	O
Fe	O
exposure	O
of	O
cells	O
in	O
BSS	O
followed	O
by	O
washing	O
,	O
change	O
of	O
medium	O
,	O
and	O
a	O
23	O
h	O
incubation	O
in	O
non	O
-	O
supplemented	O
minimum	O
essential	O
medium	O
(	O
MEM	O
)	O
(	O
i	O
.	O
e	O
.	O
with	O
very	O
low	O
Fe	O
content	O
).	O

We	O
used	O
soluble	O
Fe	O
,	O
either	O
as	O
Fe	O
(	O
III	O
)	O
maltol	O
[	O
42	O
]	O
or	O
Fe	O
(	O
II	O
)	O
sulphate	O
-	O
ascorbate	O
as	O
positive	O
controls	O
[	O
31	O
].	O

Initially	O
,	O
we	O
used	O
both	O
differentiated	O
and	O
undifferentiated	O
cells	O
and	O
iron	O
utilization	O
varied	O
greatly	O
for	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
structures	O
(	O
undifferentiated	O
>	O
differentiated	O
;	O
p	O
=	O
0	O
.	O
0003	O
)	O
but	O
not	O
at	O
all	O
for	O
the	O
soluble	O
Fe	O
(	O
III	O
)	O
(	O
Figure	O
2A	O
).	O

Alkaline	B-GP
phosphatase	I-GP
levels	O
were	O
used	O
as	O
a	O
marker	O
for	O
Caco	O
-	O
2	O
cell	O
differentiation	O
and	O
the	O
integrity	O
of	O
the	O
cell	O
monolayer	O
was	O
assured	O
prior	O
to	O
the	O
experiments	O
(	O
see	O
Figure	O
S1	O
).	O

The	O
solid	O
phase	O
distribution	O
,	O
i	O
.	O
e	O
.	O
the	O
partition	O
of	O
the	O
Fe	O
in	O
the	O
soluble	O
,	O
nanoparticulate	O
(	O
aquated	O
)	O
or	O
microparticulate	O
(	O
agglomerated	O
)	O
fractions	O
,	O
largely	O
confirmed	O
the	O
nanoparticulate	O
nature	O
of	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
and	O
the	O
solubility	O
of	O
the	O
Fe	O
(	O
III	O
)	O
maltol	O
and	O
Fe	O
(	O
II	O
)	O
sulphate	O
-	O
ascorbate	O
(	O
Figure	O
2B	O
).	O

Cellular	O
uptake	O
and	O
utilization	O
of	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
required	O
nano	O
dispersion	O
because	O
purposeful	O
agglomeration	O
to	O
microparticles	O
(	O
first	O
hour	O
in	O
MEM	O
,	O
rather	O
than	O
in	O
BSS	O
,	O
leading	O
to	O
97	O
±	O
2	O
%	O
microparticulate	O
iron	O
at	O
30	O
min	O
)	O
prevented	O
iron	O
utilization	O
(	O
Figure	O
2C	O
).	O

We	O
confirmed	O
that	O
BSS	O
did	O
not	O
affect	O
monolayer	O
integrity	O
for	O
the	O
duration	O
of	O
the	O
exposure	O
(	O
Figure	O
2D	O
)	O
although	O
Fe	O
(	O
II	O
)	O
sulphate	O
-	O
ascorbate	O
did	O
[	O
31	O
],	O
so	O
further	O
cellular	O
work	O
used	O
Fe	O
(	O
III	O
)	O
maltol	O
as	O
the	O
soluble	O
control	O
.	O

Ferritin	B-GP
-	O
protein	O
levels	O
in	O
Caco	O
-	O
2	O
cells	O
following	O
exposure	O
to	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
nano	O
Fe	O
),	O
Fe	O
(	O
III	O
)	O
maltol	O
(	O
FeM	O
)	O
or	O
Fe	O
(	O
II	O
)	O
sulphate	O
-	O
ascorbate	O
(	O
FeSO4	O
+	O
AA	O
).	O

A	O
,	O
Ferritin	B-GP
-	O
protein	O
regulation	O
in	O
differentiated	O
and	O
undifferentiated	O
cells	O
.	O
***,	O
p	O
=	O
0	O
.	O
0003	O
.	O

Cells	O
were	O
incubated	O
for	O
1	O
h	O
with	O
200	O
μM	O
Fe	O
plus	O
a	O
further	O
23	O
h	O
in	O
fresh	O
,	O
non	O
-	O
supplemented	O
MEM	O
to	O
allow	O
for	O
ferritin	B-GP
formation	O
.	O
B	O
,	O
Phase	O
distribution	O
of	O
Fe	O
in	O
the	O
BSS	O
uptake	O
medium	O
:	O
i	O
.	O
e	O
.	O
fractional	O
percentage	O
of	O
microparticulate	O
(	O
black	O
bars	O
),	O
nanoparticulate	O
(	O
red	O
bars	O
)	O
and	O
soluble	O
Fe	O
(	O
open	O
bars	O
)	O
for	O
each	O
Fe	O
material	O
.	O

Values	O
are	O
mean	O
±	O
s	O
.	O
d	O
.	O
of	O
3	O
independent	O
experiments	O
.	O
C	O
,	O
Effect	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
particle	O
dispersion	O
(	O
in	O
BSS	O
medium	O
,	O
closed	O
bars	O
)	O
or	O
agglomeration	O
(	O
in	O
MEM	O
medium	O
,	O
open	O
bars	O
)	O
on	O
ferritin	B-GP
-	O
protein	O
levels	O
in	O
differentiated	O
cells	O
:	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
was	O
dispersed	O
in	O
its	O
nano	O
-	O
form	O
(	O
99	O
±	O
2	O
%	O
nano	O
)	O
using	O
BSS	O
or	O
agglomerated	O
(	O
97	O
±	O
2	O
%	O
microparticulate	O
)	O
using	O
MEM	O
.	O

Data	O
are	O
mean	O
of	O
3	O
independent	O
experiments	O
(	O
each	O
experiment	O
with	O
3	O
replicate	O
wells	O
).	O

FeM	O
:	O
soluble	O
iron	O
control	O
,	O
Fe	O
(	O
III	O
)	O
maltol	O
.	O
***,	O
p	O
=	O
0	O
.	O
0002	O
for	O
the	O
comparison	O
between	O
BSS	O
and	O
MEM	O
.	O
D	O
,	O
TEER	O
changes	O
in	O
differentiated	O
Caco	O
-	O
2	O
cell	O
monolayer	O
at	O
different	O
time	O
points	O
during	O
incubation	O
with	O
BSS	O
supplemented	O
with	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
open	O
circles	O
)	O
or	O
non	O
-	O
supplemented	O
BSS	O
control	O
(	O
closed	O
inverted	O
triangles	O
).	O

Incubations	O
were	O
for	O
3	O
h	O
with	O
200	O
μM	O
Fe	O
(	O
measurements	O
at	O
1	O
,	O
2	O
&	O
3	O
h	O
)	O
plus	O
a	O
further	O
21	O
h	O
in	O
fresh	O
,	O
non	O
-	O
supplemented	O
MEM	O
(	O
24	O
-	O
h	O
).	O

Values	O
are	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
initial	O
measurement	O
and	O
are	O
shown	O
as	O
mean	O
±	O
s	O
.	O
d	O
.	O
of	O
3	O
independent	O
experiments	O
(	O
each	O
experiment	O
with	O
3	O
replicate	O
wells	O
).	O

Experimental	O
points	O
are	O
connected	O
with	O
a	O
solid	O
line	O
to	O
aid	O
visualization	O
and	O
not	O
because	O
a	O
linear	O
relationship	O
is	O
assumed	O
between	O
time	O
and	O
TEER	O
measurement	O
.	O

Detailed	O
methodology	O
is	O
available	O
in	O
the	O
Methods	O
Section	O
and	O
in	O
Methods	O
S1	O
.	O

Hence	O
,	O
the	O
uptake	O
and	O
utilization	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
required	O
its	O
dispersion	O
in	O
nanoparticulate	O
form	O
(	O
Figure	O
2C	O
)	O
and	O
the	O
mechanism	O
of	O
acquisition	O
appeared	O
different	O
to	O
that	O
of	O
soluble	O
Fe	O
(	O
Figure	O
2a	O
).	O

Next	O
we	O
investigated	O
energy	O
requirements	O
for	O
Fe	O
uptake	O
by	O
comparing	O
data	O
at	O
37	O
°	O
C	O
with	O
those	O
at	O
low	O
temperature	O
(	O
i	O
.	O
e	O
.	O
on	O
ice	O
).	O

Fe	O
utilization	O
from	O
Fe	O
(	O
III	O
)	O
maltol	O
at	O
low	O
temperature	O
was	O
decreased	O
by	O
95	O
%	O
(	O
95	O
±	O
1	O
;	O
n	O
=	O
3	O
)	O
as	O
expected	O
,	O
but	O
from	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
the	O
reduction	O
was	O
only	O
ca	O
.	O

20	O
%	O
(	O
19	O
±	O
13	O
;	O
n	O
=	O
3	O
)	O
(	O
Figure	O
S2	O
).	O

Apparent	O
low	O
temperature	O
uptake	O
of	O
nanoparticles	O
has	O
been	O
observed	O
before	O
[	O
43	O
,	O
44	O
]	O
and	O
is	O
attributed	O
to	O
particle	O
adhesion	O
to	O
the	O
cell	O
membrane	O
.	O

Adherent	O
particles	O
,	O
that	O
withstand	O
washing	O
,	O
may	O
be	O
subsequently	O
taken	O
up	O
by	O
cells	O
(	O
and	O
in	O
this	O
case	O
utilized	O
to	O
form	O
ferritin	B-GP
-	O
protein	O
,	O
indicating	O
that	O
cells	O
remained	O
healthy	O
)	O
upon	O
re	O
-	O
incubation	O
in	O
fresh	O
medium	O
at	O
37	O
°	O
C	O
.	O

Electron	O
microscopy	O
indicated	O
cell	O
surface	O
adhesion	O
of	O
the	O
nanoparticles	O
and	O
also	O
showed	O
that	O
,	O
generally	O
,	O
the	O
cell	O
membrane	O
tended	O
to	O
induce	O
loose	O
agglomeration	O
or	O
aggregation	O
of	O
the	O
particles	O
into	O
clusters	O
up	O
to	O
200	O
nm	O
in	O
diameter	O
(	O
Figure	O
3A	O
).	O

Thus	O
we	O
considered	O
that	O
Fe	O
from	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
was	O
utilized	O
following	O
acquisition	O
by	O
endocytic	O
uptake	O
,	O
as	O
this	O
is	O
superior	O
in	O
undifferentiated	O
versus	O
differentiated	O
Caco	O
-	O
2	O
cells	O
[	O
45	O
],	O
and	O
cell	O
surface	O
adhesion	O
is	O
a	O
requirement	O
prior	O
to	O
uptake	O
.	O

Indeed	O
further	O
electron	O
microscopy	O
work	O
revealed	O
evidence	O
of	O
cell	O
surface	O
invagination	O
(	O
Figure	O
3B	O
)	O
with	O
respect	O
to	O
the	O
surface	O
clusters	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
and	O
showed	O
loose	O
agglomerates	O
of	O
≤	O
200	O
nm	O
in	O
diameter	O
within	O
vesicles	O
that	O
we	O
suggest	O
are	O
endosomes	O
or	O
lysosomes	O
(	O
Figure	O
3C	O
,	O
D	O
).	O

TEM	O
images	O
were	O
also	O
collected	O
for	O
control	O
Caco	O
-	O
2	O
cells	O
:	O
i	O
.	O
e	O
.	O
cells	O
incubated	O
with	O
non	O
-	O
supplemented	O
BSS	O
and	O
cells	O
incubated	O
with	O
BSS	O
supplemented	O
with	O
the	O
soluble	O
Fe	O
(	O
III	O
)	O
maltol	O
chelate	O
and	O
no	O
discernible	O
particulate	O
Fe	O
was	O
observed	O
(	O
Figure	O
S3	O
).	O

To	O
determine	O
whether	O
nanoparticulate	O
uptake	O
contributed	O
to	O
cellular	O
Fe	O
utilization	O
of	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
we	O
used	O
an	O
inhibitor	O
of	O
clathrin	B-GP
-	O
mediated	O
endocytosis	O
,	O
namely	O
chlorpromazine	O
,	O
at	O
a	O
dose	O
of	O
100	O
μM	O
consistent	O
with	O
previous	O
studies	O
[	O
32	O
,	O
33	O
].	O

We	O
confirmed	O
that	O
this	O
significantly	O
reduced	O
(	O
p	O
=	O
0	O
.	O
02	O
)	O
ferritin	B-GP
-	O
protein	O
formation	O
in	O
the	O
cells	O
exposed	O
to	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
Figure	O
3E	O
),	O
without	O
significantly	O
affecting	O
monolayer	O
integrity	O
(	O
Figure	O
3F	O
),	O
whilst	O
no	O
difference	O
was	O
observed	O
for	O
soluble	O
iron	O
uptake	O
(	O
Figure	O
3E	O
,	O
F	O
).	O

Further	O
endocytic	O
-	O
inhibition	O
studies	O
with	O
K	O
+	O
depletion	O
,	O
filipin	O
and	O
methyl	O
-	O
β	O
-	O
cyclodextrin	O
suggested	O
the	O
same	O
picture	O
:	O
namely	O
that	O
Fe	O
utilization	O
appeared	O
reduced	O
albeit	O
so	O
only	O
for	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
exposure	O
and	O
not	O
for	O
soluble	O
Fe	O
(	O
Figure	O
3D	O
).	O

Interestingly	O
,	O
filipin	O
and	O
methyl	O
-	O
β	O
-	O
cyclodextrin	O
inhibit	O
caveolae	O
-	O
related	O
rather	O
than	O
clathrin	B-GP
-	O
mediated	O
endocytosis	O
so	O
,	O
consistent	O
with	O
previous	O
nanoparticulate	O
uptake	O
work	O
,	O
there	O
either	O
appears	O
to	O
be	O
a	O
degree	O
of	O
redundancy	O
/	O
overlap	O
between	O
the	O
uptake	O
pathways	O
[	O
43	O
]	O
or	O
precise	O
uptake	O
may	O
be	O
related	O
to	O
the	O
size	O
range	O
of	O
the	O
nanoparticulate	O
clusters	O
formed	O
on	O
the	O
cell	O
membrane	O
[	O
46	O
–	O
49	O
].	O

All	O
cell	O
monolayers	O
appeared	O
healthy	O
under	O
the	O
microscope	O
,	O
and	O
also	O
without	O
significant	O
changes	O
in	O
TEER	O
measurements	O
,	O
under	O
the	O
assay	O
conditions	O
used	O
with	O
K	O
+-	O
free	O
BSS	O
and	O
methyl	O
-	O
β	O
-	O
cyclodextrin	O
(	O
Figure	O
3F	O
),	O
although	O
no	O
TEER	O
assessment	O
was	O
made	O
with	O
filipin	O
.	O

Cellular	O
uptake	O
of	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
by	O
Caco	O
-	O
2	O
cells	O
.	O

A	O
,	O
B	O
,	O
C	O
,	O
D	O
TEM	O
images	O
showing	O
differentiated	O
Caco	O
-	O
2	O
cells	O
incubated	O
with	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
.	O
A	O
,	O
arrows	O
show	O
particle	O
clusters	O
adhering	O
to	O
the	O
cell	O
membrane	O
microvilli	O
(	O
scale	O
bar	O
,	O
500	O
nm	O
).	O
B	O
,	O
arrows	O
indicate	O
invagination	O
on	O
the	O
cell	O
membrane	O
(	O
scale	O
bar	O
,	O
100	O
nm	O
).	O
C	O
and	O
D	O
,	O
arrows	O
indicate	O
Fe	O
accumulation	O
inside	O
the	O
cell	O
(	O
scale	O
bars	O
:	O
panel	O
C	O
,	O
500	O
nm	O
and	O
panel	O
D	O
,	O
100	O
nm	O
).	O
E	O
,	O
Effect	O
of	O
chemical	O
inhibitors	O
of	O
endocytosis	O
-	O
related	O
pathways	O
on	O
Fe	O
utilization	O
by	O
differentiated	O
Caco	O
-	O
2	O
cells	O
.	O

Data	O
are	O
shown	O
as	O
a	O
percentage	O
of	O
the	O
controls	O
(	O
without	O
inhibitor	O
)	O
after	O
a	O
1	O
h	O
exposure	O
to	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
black	O
bars	O
)	O
or	O
Fe	O
(	O
III	O
)	O
maltol	O
(	O
open	O
bars	O
)	O
co	O
-	O
incubated	O
with	O
either	O
chlorpromazine	O
(	O
CPZ	O
),	O
potassium	O
-	O
free	O
BSS	O
(	O
K	O
+	O
depletion	O
),	O
filipin	O
or	O
methyl	O
-	O
β	O
-	O
cyclodextrin	O
(	O
M	O
-	O
β	O
-	O
c	O
),	O
plus	O
23	O
h	O
in	O
fresh	O
non	O
-	O
supplemented	O
MEM	O
.	O

Results	O
are	O
mean	O
±	O
s	O
.	O
d	O
.	O
of	O
3	O
independent	O
experiments	O
with	O
3	O
replicate	O
wells	O
per	O
experiment	O
for	O
chlorpromazine	O
(*,	O
p	O
=	O
0	O
.	O
02	O
relative	O
to	O
control	O
)	O
or	O
triplicate	O
wells	O
of	O
the	O
same	O
experiment	O
for	O
the	O
remaining	O
inhibitors	O
.	O
F	O
,	O
Change	O
in	O
TEER	O
in	O
the	O
Caco	O
-	O
2	O
cell	O
monolayer	O
following	O
a	O
1	O
h	O
exposure	O
to	O
chlorpromazine	O
(	O
closed	O
diamonds	O
),	O
K	O
+-	O
free	O
BSS	O
(	O
open	O
triangles	O
),	O
M	O
-	O
β	O
-	O
c	O
(	O
open	O
squares	O
)	O
or	O
non	O
-	O
supplemented	O
BSS	O
(	O
closed	O
inverted	O
triangles	O
)	O
and	O
with	O
23	O
h	O
further	O
incubation	O
in	O
fresh	O
MEM	O
(	O
24	O
h	O
total	O
).	O

Values	O
are	O
a	O
percentage	O
of	O
the	O
initial	O
measurement	O
(	O
0	O
h	O
)	O
and	O
are	O
shown	O
as	O
mean	O
±	O
s	O
.	O
d	O
.	O
as	O
above	O
.	O

Experimental	O
points	O
are	O
connected	O
with	O
a	O
solid	O
line	O
to	O
aid	O
visualization	O
and	O
not	O
because	O
a	O
linear	O
relationship	O
is	O
assumed	O
between	O
time	O
and	O
TEER	O
measurement	O
.	O

Detailed	O
methodology	O
is	O
available	O
in	O
the	O
Methods	O
Section	O
and	O
in	O
Methods	O
S1	O
.	O

Lysosomal	O
dissolution	O
of	O
ligand	O
-	O
modified	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
enables	O
cellular	O
utilization	O
of	O
iron	O

Overall	O
,	O
direct	O
endocytosis	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
by	O
differentiated	O
Caco	O
-	O
2	O
cells	O
appears	O
,	O
chiefly	O
,	O
to	O
explain	O
uptake	O
of	O
Fe	O
under	O
these	O
conditions	O
.	O

However	O
,	O
this	O
Fe	O
still	O
needs	O
to	O
be	O
released	O
for	O
cellular	O
utilization	O
(	O
i	O
.	O
e	O
.	O
ferritin	B-GP
-	O
protein	O
synthesis	O
in	O
the	O
current	O
cell	O
assay	O
)	O
and	O
there	O
would	O
be	O
insufficient	O
intracellular	O
(	O
lysosomal	O
)	O
acidification	O
for	O
this	O
alone	O
to	O
drive	O
the	O
release	O
and	O
cytosolic	O
iron	O
transit	O
.	O

Skotland	O
et	O
al	O
.	O
[	O
50	O
]	O
developed	O
a	O
simplified	O
endosomal	O
/	O
lysosomal	O
solution	O
that	O
included	O
10	O
mM	O
citrate	O
and	O
this	O
chelator	O
might	O
,	O
when	O
aided	O
by	O
endosomal	O
/	O
lysosomal	O
acidification	O
,	O
enable	O
the	O
breakdown	O
and	O
release	O
of	O
Fe	O
from	O
these	O
fine	O
,	O
ligand	O
-	O
destabilized	O
ferrihydrite	O
-	O
like	O
particles	O
.	O

We	O
showed	O
that	O
under	O
these	O
simplified	O
endosomal	O
/	O
lysosomal	O
conditions	O
soluble	O
Fe	O
could	O
be	O
released	O
within	O
hours	O
from	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
ferrihydrite	O
)	O
structures	O
at	O
pH	O
5	O
.	O
0	O
(	O
Figure	O
4A	O
)	O
whereas	O
,	O
in	O
the	O
absence	O
of	O
ligand	O
modification	O
,	O
the	O
native	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
was	O
poorly	O
broken	O
down	O
and	O
little	O
soluble	O
Fe	O
was	O
released	O
(	O
Figure	O
4A	O
).	O

This	O
‘	O
destabilization	O
’	O
role	O
of	O
low	O
molecular	O
weight	O
ligands	O
in	O
the	O
nano	O
-	O
structured	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
indicates	O
a	O
more	O
likely	O
physiological	O
role	O
for	O
them	O
in	O
the	O
gut	O
lumen	O
rather	O
than	O
,	O
as	O
originally	O
proposed	O
[	O
19	O
],	O
as	O
donors	O
of	O
Fe	O
(	O
III	O
)	O
to	O
mucin	B-GP
.	O

Next	O
,	O
using	O
cell	O
studies	O
and	O
monensin	O
to	O
inhibit	O
endosomal	O
/	O
lysosomal	O
acidification	O
[	O
39	O
],	O
we	O
showed	O
a	O
monensin	O
-	O
dose	O
-	O
dependent	O
reduction	O
(	O
i	O
.	O
e	O
.	O
Log10	O
[	O
monensin	O
]	O
versus	O
[	O
ferritin	B-GP
-	O
protein	O
],	O
r2	O
=	O
0	O
.	O
935	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
Fe	O
utilization	O
by	O
differentiated	O
Caco	O
-	O
2	O
cells	O
when	O
exposed	O
to	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
Figure	O
4B	O
),	O
with	O
statistically	O
significant	O
inhibition	O
of	O
ferritin	B-GP
formation	O
at	O
monensin	O
doses	O
≥	O
7	O
.	O
5	O
µM	O
(	O
p	O
=	O
0	O
.	O
002	O
).	O

Again	O
,	O
soluble	O
Fe	O
was	O
unaffected	O
.	O

The	O
monensin	O
doses	O
used	O
here	O
were	O
equivalent	O
to	O
those	O
reported	O
previously	O
in	O
inhibition	O
studies	O
of	O
endosomal	O
/	O
lysosomal	O
acidification	O
in	O
Caco	O
-	O
2	O
cells	O
[	O
51	O
,	O
52	O
]	O
or	O
other	O
cell	O
types	O
[	O
53	O
,	O
54	O
],	O
even	O
though	O
by	O
24	O
h	O
some	O
disruption	O
of	O
the	O
monolayer	O
was	O
visible	O
by	O
TEER	O
measurements	O
particularly	O
at	O
the	O
highest	O
monensin	O
dose	O
(	O
Figure	O
4C	O
).	O

Nonetheless	O
,	O
the	O
monolayer	O
was	O
intact	O
during	O
the	O
1	O
hour	O
cell	O
exposure	O
to	O
Fe	O
(	O
Figure	O
4C	O
)	O
and	O
,	O
when	O
examined	O
microscopically	O
,	O
the	O
cell	O
monolayers	O
appeared	O
integral	O
and	O
healthy	O
at	O
doses	O
of	O
monensin	O
up	O
to	O
10	O
µM	O
which	O
still	O
greatly	O
inhibited	O
ferritin	B-GP
-	O
protein	O
formation	O
(	O
Figure	O
4B	O
),	O
and	O
there	O
were	O
similar	O
protein	O
levels	O
in	O
the	O
presence	O
and	O
absence	O
of	O
the	O
inhibitor	O
(	O
Figure	O
S4	O
).	O

Lysososmal	O
dissolution	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
.	O

A	O
,	O
Solubility	O
in	O
simulated	O
lysosomal	O
conditions	O
at	O
pH	O
5	O
.	O
0	O
with	O
10	O
mM	O
citric	O
acid	O
and	O
0	O
.	O
15	O
M	O
NaCl	O
.	O

Soluble	O
Fe	O
was	O
measured	O
by	O
ICP	O
-	O
OES	O
following	O
5	O
min	O
ultrafiltration	O
(	O
3000	O
Da	O
MWCO	O
)	O
for	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
black	O
)	O
and	O
for	O
un	O
-	O
modified	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
solid	O
blue	O
).	O

Nanoparticulate	O
Fe	O
was	O
obtained	O
from	O
the	O
Fe	O
in	O
the	O
supernatant	O
following	O
centrifugation	O
excluding	O
the	O
soluble	O
(	O
ultrafilterable	O
)	O
Fe	O
,	O
and	O
is	O
shown	O
for	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
red	O
)	O
and	O
for	O
un	O
-	O
modified	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
dotted	O
blue	O
).	O

Values	O
are	O
plotted	O
as	O
mean	O
±	O
s	O
.	O
d	O
.	O
of	O
3	O
independent	O
experiments	O
(	O
each	O
experiment	O
with	O
3	O
replicates	O
).	O
B	O
,	O
Effect	O
of	O
inhibition	O
of	O
lysosomal	O
acidification	O
using	O
monensin	O
on	O
Fe	O
utilization	O
by	O
differentiated	O
Caco	O
-	O
2	O
cells	O
.	O

Data	O
are	O
shown	O
as	O
a	O
percentage	O
of	O
the	O
control	O
(	O
without	O
monensin	O
)	O
at	O
24	O
h	O
:	O
i	O
.	O
e	O
.	O
1	O
h	O
exposure	O
to	O
200	O
µM	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
open	O
circles	O
)	O
or	O
Fe	O
(	O
III	O
)	O
maltol	O
(	O
closed	O
squares	O
)	O
±	O
5	O
-	O
30	O
µM	O
monensin	O
followed	O
by	O
23	O
h	O
in	O
non	O
-	O
supplemented	O
MEM	O
.	O

Results	O
are	O
means	O
±	O
s	O
.	O
d	O
.	O
of	O
3	O
independent	O
experiments	O
(	O
each	O
experiment	O
with	O
3	O
replicate	O
wells	O
).	O
**,	O
p	O
<	O
0	O
.	O
005	O
;	O
***,	O
p	O
<	O
0	O
.	O
001	O
in	O
relation	O
to	O
the	O
soluble	O
Fe	O
control	O
(	O
Fe	O
(	O
III	O
)	O
maltol	O
).	O
C	O
,	O
Change	O
in	O
TEER	O
in	O
the	O
Caco	O
-	O
2	O
cell	O
monolayer	O
following	O
1	O
h	O
exposure	O
to	O
10	O
μM	O
monensin	O
(	O
closed	O
squares	O
),	O
30	O
μM	O
monensin	O
(	O
open	O
diamonds	O
)	O
or	O
non	O
-	O
supplemented	O
BSS	O
control	O
(	O
closed	O
inverted	O
triangles	O
)	O
and	O
with	O
23	O
h	O
further	O
incubation	O
in	O
fresh	O
MEM	O
(	O
24	O
h	O
in	O
total	O
).	O

Values	O
are	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
initial	O
measurement	O
at	O
the	O
start	O
of	O
the	O
exposure	O
time	O
(	O
corresponding	O
to	O
0	O
h	O
)	O
and	O
are	O
shown	O
as	O
mean	O
±	O
s	O
.	O
d	O
.	O
of	O
2	O
independent	O
experiments	O
(	O
each	O
experiment	O
with	O
3	O
replicate	O
wells	O
).	O

Experimental	O
points	O
are	O
connected	O
with	O
a	O
solid	O
line	O
to	O
aid	O
visualization	O
and	O
not	O
because	O
a	O
linear	O
relationship	O
is	O
assumed	O
between	O
time	O
and	O
TEER	O
measurement	O
.	O
***,	O
p	O
=	O
0	O
.	O
0003	O
;	O
****,	O
p	O
<	O
0	O
.	O
0001	O
in	O
relation	O
to	O
the	O
non	O
-	O
supplemented	O
BSS	O
control	O
.	O

Finally	O
,	O
we	O
confirmed	O
that	O
none	O
of	O
the	O
inhibitors	O
caused	O
significant	O
agglomeration	O
of	O
the	O
nanoparticles	O
in	O
the	O
supplemented	O
uptake	O
medium	O
(	O
Table	O
S1	O
).	O

Overall	O
Discussion	O

The	O
Caco	O
-	O
2	O
cell	O
line	O
has	O
been	O
extensively	O
used	O
for	O
iron	O
uptake	O
studies	O
[	O
55	O
–	O
59	O
]	O
as	O
following	O
confluence	O
it	O
differentiates	O
into	O
a	O
polarised	O
cell	O
monolayer	O
that	O
exhibits	O
a	O
phenotype	O
similar	O
to	O
human	B-OG
small	O
intestinal	O
enterocytes	O
[	O
60	O
,	O
61	O
].	O

Our	O
data	O
suggest	O
that	O
an	O
endocytic	O
,	O
apical	O
uptake	O
mechanism	O
exists	O
in	O
these	O
differentiated	O
Caco	O
-	O
2	O
cells	O
for	O
uptake	O
of	O
luminally	O
hydrolysed	O
(	O
poly	O
oxo	O
-	O
hydroxide	O
)	O
dietary	O
Fe	O
(	O
III	O
).	O

This	O
route	O
apparently	O
relies	O
on	O
endocytic	O
uptake	O
of	O
small	O
clusters	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
which	O
agglomerate	O
at	O
the	O
cell	O
membrane	O
.	O

Many	O
cellular	O
studies	O
on	O
nanoparticulate	O
uptake	O
and	O
processing	O
are	O
challenged	O
with	O
issues	O
of	O
agglomeration	O
and	O
aggregation	O
meaning	O
that	O
,	O
finally	O
,	O
cells	O
are	O
exposed	O
to	O
micron	O
-	O
sized	O
clusters	O
which	O
will	O
be	O
acquired	O
and	O
processed	O
differently	O
compared	O
to	O
genuinely	O
disperse	O
nanostructures	O
[	O
46	O
,	O
62	O
,	O
63	O
].	O

Thus	O
we	O
paid	O
considerable	O
attention	O
to	O
developing	O
a	O
cell	O
culture	O
medium	O
that	O
mitigated	O
against	O
such	O
pitfalls	O
and	O
retained	O
appropriate	O
dispersion	O
of	O
the	O
particles	O
prior	O
to	O
cell	O
delivery	O
[	O
31	O
].	O

The	O
finding	O
that	O
these	O
fine	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
then	O
tend	O
to	O
agglomerate	O
at	O
the	O
cell	O
membrane	O
must	O
be	O
interpreted	O
with	O
caution	O
.	O

It	O
could	O
be	O
that	O
the	O
processing	O
required	O
to	O
produce	O
thin	O
sections	O
for	O
electron	O
microscopy	O
induced	O
clustering	O
.	O

However	O
,	O
small	O
agglomerates	O
of	O
nanoparticles	O
were	O
observed	O
in	O
endosomal	O
/	O
lysosomal	O
compartments	O
within	O
the	O
cell	O
and	O
,	O
so	O
,	O
the	O
particles	O
must	O
have	O
been	O
taken	O
up	O
either	O
as	O
individual	O
particles	O
or	O
clusters	O
.	O

Moreover	O
,	O
and	O
importantly	O
,	O
we	O
observed	O
loose	O
clusters	O
almost	O
always	O
smaller	O
than	O
200	O
nm	O
diameter	O
and	O
it	O
is	O
at	O
around	O
this	O
size	O
that	O
uptake	O
mechanisms	O
may	O
switch	O
between	O
classical	O
endocytosis	O
and	O
macropinocytosis	O
[	O
46	O
,	O
64	O
].	O

There	O
appears	O
to	O
be	O
no	O
mechanism	O
of	O
macropinocytosis	O
in	O
intestinal	O
enterocytes	O
,	O
including	O
differentiated	O
Caco	O
-	O
2	O
cells	O
,	O
and	O
phagocytosis	O
has	O
been	O
rarely	O
demonstrated	O
[	O
65	O
,	O
66	O
].	O

The	O
inhibitors	O
used	O
here	O
were	O
classical	O
endocytic	O
inhibitors	O
and	O
our	O
findings	O
suggest	O
endocytosis	O
of	O
individual	O
particles	O
or	O
membrane	O
-	O
induced	O
small	O
clusters	O
.	O

We	O
accept	O
that	O
the	O
specificity	O
of	O
K	O
+-	O
depletion	O
to	O
clathrin	B-GP
-	O
mediated	O
endocytosis	O
and	O
methyl	O
-	O
β	O
-	O
cyclodextrin	O
to	O
caveolin	B-GP
-	O
dependent	O
endocytosis	O
in	O
HuTu	O
cells	O
has	O
been	O
previously	O
questioned	O
[	O
34	O
].	O

However	O
,	O
chlorpromazine	O
has	O
been	O
consistently	O
shown	O
to	O
be	O
highly	O
specific	O
for	O
clathrin	B-GP
-	O
mediated	O
endocytosis	O
in	O
both	O
HuTu	O
and	O
Caco	O
-	O
2	O
cells	O
,	O
providing	O
comparable	O
inhibition	O
rates	O
to	O
siRNA	O
approaches	O
[	O
34	O
,	O
67	O
].	O

Filipin	O
also	O
appears	O
specific	O
to	O
caveolin	B-GP
-	O
dependent	O
endocytosis	O
[	O
35	O
,	O
68	O
].	O

Nonetheless	O
,	O
we	O
do	O
not	O
,	O
here	O
,	O
suggest	O
dominance	O
of	O
one	O
specific	O
form	O
of	O
endocytosis	O
for	O
the	O
uptake	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
as	O
further	O
work	O
may	O
be	O
required	O
to	O
conclude	O
on	O
this	O
.	O

Our	O
observations	O
on	O
Fe	O
utilization	O
by	O
Caco	O
-	O
2	O
cells	O
,	O
through	O
endocytic	O
uptake	O
and	O
lysosomal	O
dissolution	O
of	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
,	O
are	O
still	O
consistent	O
with	O
the	O
established	O
fact	O
that	O
DMT	B-GP
-	I-GP
1	I-GP
is	O
indispensable	O
for	O
mammalian	O
Fe	O
absorption	O
and	O
,	O
therefore	O
,	O
survival	O
[	O
69	O
].	O

DMT	B-GP
-	I-GP
1	I-GP
,	O
as	O
well	O
as	O
being	O
the	O
enterocyte	O
Fe	B-GP
(	I-GP
II	I-GP
)	I-GP
apical	I-GP
transporter	I-GP
is	O
probably	O
also	O
the	O
export	O
transporter	O
of	O
the	O
lysosomal	O
membrane	O
[	O
70	O
–	O
72	O
]:	O
i	O
.	O
e	O
.	O
the	O
point	O
from	O
where	O
endocytosed	O
and	O
then	O
solubilized	O
nanoparticulate	O
Fe	O
would	O
join	O
the	O
common	O
Fe	O
pool	O
.	O

The	O
elegant	O
study	O
of	O
Gunshin	O
et	O
al	O
.	O
[	O
69	O
],	O
utilizing	O
an	O
intestinal	O
-	O
specific	O
DMT	B-GP
-	I-GP
1	I-GP
knock	O
-	O
out	O
model	O
termed	O
Slc11a2int	O
/	O
int	O
(	O
which	O
is	O
a	O
cross	O
of	O
Slc11a2flox	O
/	O
flox	O
mice	B-OG
with	O
mice	B-OG
carrying	O
a	O
Villin	B-GP
-	O
Cre	B-GP
transgene	O
),	O
proved	O
essentiality	O
of	O
this	O
transporter	O
for	O
intestinal	O
non	O
-	O
haem	O
iron	O
absorption	O
after	O
birth	O
[	O
69	O
].	O

However	O
,	O
the	O
Slc11a2int	O
/	O
int	O
model	O
has	O
DMT1	B-GP
knocked	O
-	O
out	O
in	O
the	O
entire	O
enterocyte	O
and	O
not	O
solely	O
from	O
the	O
apical	O
membrane	O
[	O
69	O
]	O
and	O
,	O
therefore	O
,	O
this	O
study	O
did	O
not	O
eliminate	O
DMT	B-GP
-	I-GP
1	I-GP
functionality	O
in	O
both	O
apical	O
uptake	O
and	O
cytosolic	O
processing	O
of	O
intracellular	O
iron	O
.	O
A	O
further	O
point	O
is	O
that	O
laboratory	O
rodent	O
diets	O
poorly	O
represent	O
the	O
human	B-OG
diet	O
.	O

Invariably	O
the	O
laboratory	O
diet	O
is	O
rich	O
in	O
fibrous	O
carbohydrate	O
that	O
is	O
poorly	O
digestible	O
in	O
the	O
upper	O
gastrointestinal	O
tract	O
and	O
will	O
bind	O
Fe	O
(	O
III	O
)	O
thereby	O
preventing	O
mucosal	O
access	O
.	O

Thus	O
,	O
Fe	O
(	O
II	O
)	O
sulphate	O
is	O
commonly	O
supplemented	O
into	O
rodent	O
laboratory	O
chow	O
,	O
as	O
for	O
example	O
in	O
the	O
RMH	O
3000	O
LabDiet	O
(	O
PMI	O
Nutrition	O
International	O
)	O
used	O
by	O
Gunshin	O
et	O
al	O
.	O
in	O
the	O
study	O
referred	O
to	O
above	O
[	O
69	O
].	O

In	O
this	O
case	O
,	O
the	O
essentiality	O
of	O
an	O
Fe	B-GP
(	I-GP
II	I-GP
)	I-GP
transporter	I-GP
would	O
be	O
favoured	O
.	O

Future	O
in	O
vivo	O
rodent	O
experiments	O
could	O
use	O
a	O
diet	O
representing	O
the	O
more	O
varied	O
human	B-OG
diet	O
for	O
non	O
-	O
heme	O
Fe	O
(	O
e	O
.	O
g	O
.,	O
mixed	O
Fe	O
(	O
II	O
)-	O
Fe	O
(	O
III	O
)	O
salts	O
that	O
undergo	O
gastric	O
dissolution	O
,	O
plus	O
ferritin	B-GP
-	O
protein	O
)	O
and	O
then	O
establish	O
,	O
in	O
the	O
Slc11a2int	O
/	O
int	O
mouse	B-OG
,	O
whether	O
or	O
not	O
there	O
is	O
enterocyte	O
lysosomal	O
accumulation	O
of	O
Fe	O
(	O
i	O
.	O
e	O
.	O
initial	O
apical	O
uptake	O
due	O
to	O
a	O
non	O
DMT	B-GP
-	I-GP
1	I-GP
pathway	O
for	O
the	O
hydrolysed	O
Fe	O
(	O
III	O
)	O
and	O
possibly	O
ferritin	B-GP
-	O
protein	O
fractions	O
,	O
but	O
accumulation	O
due	O
to	O
export	O
failure	O
with	O
lack	O
of	O
lysosomal	O
DMT	B-GP
-	I-GP
1	I-GP
).	O

Such	O
a	O
diet	O
fed	O
to	O
Slc11a2int	O
/	O
int	O
mice	B-OG
will	O
delineate	O
the	O
essential	O
role	O
of	O
DMT	B-GP
-	I-GP
1	I-GP
for	O
apical	O
iron	O
uptake	O
versus	O
lysosomal	O
iron	O
efflux	O
.	O

Indeed	O
,	O
Kalgaonkar	O
and	O
Lonnerdal	O
[	O
3	O
]	O
have	O
speculated	O
that	O
dietary	O
ferritin	B-GP
Fe	O
,	O
which	O
contains	O
subunits	O
of	O
ferrihydrite	O
similar	O
in	O
structure	O
to	O
the	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
nanoparticles	O
used	O
herein	O
[	O
73	O
],	O
may	O
not	O
all	O
be	O
dissolved	O
under	O
post	O
-	O
prandial	O
gastric	O
conditions	O
,	O
and	O
could	O
be	O
absorbed	O
whole	O
by	O
duodenal	O
enterocytes	O
and	O
subsequently	O
broken	O
down	O
intra	O
-	O
lysosomally	O
.	O

Moreover	O
,	O
elsewhere	O
in	O
mammalian	O
Fe	O
physiology	O
,	O
the	O
lysosome	O
is	O
a	O
safe	O
reservoir	O
for	O
catabolism	O
of	O
Fe	O
-	O
rich	O
species	O
,	O
whether	O
it	O
be	O
ferritin	B-GP
-	O
protein	O
,	O
red	O
blood	O
cells	O
or	O
transferrin	B-GP
turnover	O
[	O
71	O
,	O
74	O
].	O

Free	O
Fe	O
is	O
potentially	O
redox	O
active	O
and	O
thus	O
toxic	O
to	O
cells	O
.	O

So	O
the	O
concept	O
that	O
cells	O
lining	O
the	O
gut	O
are	O
protected	O
from	O
redox	O
damage	O
(	O
Fe	O
(	O
III	O
)	O
↔	O
Fe	O
(	O
II	O
)	O
+	O
e	O
-)	O
due	O
to	O
luminal	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
formation	O
,	O
which	O
is	O
only	O
available	O
for	O
breakdown	O
in	O
the	O
safest	O
compartment	O
of	O
the	O
cell	O
,	O
i	O
.	O
e	O
.	O
the	O
endosome	O
/	O
lysosome	O
,	O
is	O
consistent	O
with	O
other	O
aspects	O
of	O
Fe	O
metabolism	O
.	O

Finally	O
,	O
of	O
particular	O
note	O
,	O
is	O
a	O
paper	O
by	O
Theil	O
and	O
colleagues	O
[	O
75	O
],	O
published	O
during	O
preparation	O
of	O
this	O
manuscript	O
,	O
where	O
they	O
show	O
that	O
the	O
Fe	O
derived	O
from	O
dietary	O
ferritin	B-GP
-	O
protein	O
(	O
i	O
.	O
e	O
.	O
protein	O
-	O
encapsulated	O
ferrihydrite	O
-	O
like	O
nanostructures	O
)	O
is	O
absorbed	O
differently	O
in	O
rats	B-OG
and	O
humans	B-OG
to	O
that	O
of	O
DMT	B-GP
-	I-GP
1	I-GP
-	O
dependent	O
Fe	O
(	O
II	O
).	O

Moreover	O
,	O
their	O
findings	O
invoke	O
an	O
epithelial	O
endocytic	O
process	O
,	O
which	O
we	O
believe	O
we	O
detail	O
here	O
:	O
i	O
.	O
e	O
.	O
the	O
fraction	O
of	O
dietary	O
iron	O
derived	O
from	O
ferritin	B-GP
-	O
protein	O
ingestion	O
could	O
lose	O
its	O
protein	O
shell	O
but	O
maintain	O
its	O
ferrihydrite	O
-	O
like	O
structure	O
following	O
gastrointestinal	O
digestion	O
and	O
‘	O
ride	O
’	O
the	O
endocytic	O
mechanisms	O
that	O
exists	O
for	O
endogenously	O
formed	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
.	O

Ultimately	O
,	O
the	O
two	O
forms	O
may	O
look	O
very	O
similar	O
,	O
being	O
2	O
-	O
5	O
nm	O
diameter	O
,	O
destabilized	O
ferrihydrite	O
[	O
73	O
]	O
and	O
thus	O
,	O
readily	O
solubilized	O
by	O
the	O
enterocyte	O
endosome	O
/	O
lysosome	O
.	O

Our	O
preliminary	O
data	O
in	O
duodenal	O
epithelial	O
cells	O
(	O
HuTu	O
-	O
80	O
cell	O
line	O
)	O
using	O
siRNA	O
targeting	O
DMT1	B-GP
further	O
supports	O
a	O
pathway	O
independent	O
of	O
DMT1	B-GP
and	O
Dcyt	B-GP
B	I-GP
for	O
the	O
intestinal	O
uptake	O
of	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
and	O
,	O
thus	O
,	O
not	O
involving	O
reduction	O
of	O
Fe	O
(	O
III	O
)	O
to	O
Fe	O
(	O
II	O
)	O
(	O
Figure	O
S5	O
).	O

We	O
have	O
demonstrated	O
the	O
existence	O
of	O
a	O
nanoparticulate	O
ferrihydrite	O
-	O
like	O
phase	O
in	O
a	O
model	O
of	O
luminally	O
hydrolysed	O
Fe	O
(	O
III	O
)	O
and	O
,	O
using	O
a	O
synthetic	O
nanoparticulate	O
ligand	O
-	O
modified	O
ferrihydrite	O
as	O
an	O
analogue	O
,	O
we	O
have	O
shown	O
the	O
existence	O
of	O
an	O
endocytic	O
pathway	O
of	O
Fe	O
uptake	O
by	O
Caco	O
-	O
2	O
cells	O
,	O
a	O
gut	O
epithelial	O
cell	O
model	O
,	O
followed	O
by	O
lysosomal	O
dissolution	O
of	O
nanoparticulate	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
which	O
is	O
consistent	O
with	O
in	O
vivo	O
observations	O
elsewhere	O
[	O
75	O
].	O

These	O
in	O
vitro	O
mechanistic	O
findings	O
now	O
need	O
to	O
be	O
replicated	O
by	O
in	O
vivo	O
data	O
for	O
physiological	O
relevance	O
,	O
and	O
,	O
it	O
is	O
noteworthy	O
that	O
,	O
when	O
supplemented	O
into	O
the	O
diet	O
of	O
iron	O
deficient	O
rats	B-OG
,	O
these	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
structures	O
improved	O
haemoglobin	B-GP
levels	O
in	O
line	O
with	O
Fe	O
(	O
II	O
)	O
sulphate	O
supplementation	O
[	O
Pereira	O
,	O
Latunde	O
-	O
Dada	O
and	O
Powell	O
unpublished	O
observations	O
].	O

Supporting	O
Information	O

(	O
DOCX	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Iron	O
solid	O
-	O
phase	O
distribution	O
of	O
200	O
µM	O
Fe	O
as	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
nano	O
Fe	O
)	O
and	O
Fe	O
(	O
III	O
)	O
maltol	O
(	O
FeM	O
)	O
co	O
-	O
incubated	O
with	O
different	O
chemical	O
inhibitors	O
in	O
the	O
BSS	O
uptake	O
medium	O
.	O

(	O
DOCX	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Caco	O
-	O
2	O
cell	O
growth	O
and	O
differentiation	O
parameters	O
in	O
monolayers	O
grown	O
for	O
21	O
days	O
.	O
A	O
,	O
cell	O
protein	O
(	O
open	O
circles	O
)	O
and	O
transepithelial	O
electrical	O
resistance	O
(	O
TEER	O
,	O
closed	O
squares	O
).	O

Data	O
shown	O
are	O
mean	O
±	O
s	O
.	O
d	O
.	O
of	O
n	O
=	O
3	O
independent	O
experiments	O
(	O
each	O
experiment	O
with	O
12	O
replicate	O
wells	O
).	O
B	O
,	O
alkaline	B-GP
phosphatase	I-GP
activity	O
(	O
closed	O
triangles	O
).	O

Data	O
shown	O
are	O
mean	O
±	O
s	O
.	O
d	O
.	O
of	O
n	O
=	O
3	O
independent	O
experiments	O
(	O
each	O
experiment	O
with	O
3	O
replicate	O
wells	O
).	O

Under	O
these	O
culture	O
conditions	O
the	O
cell	O
monolayer	O
is	O
fully	O
confluent	O
at	O
day	O
5	O
post	O
-	O
seeding	O
and	O
differentiated	O
at	O
day	O
10	O
post	O
-	O
seeding	O
in	O
accordance	O
with	O
reference	O
values	O
reported	O
in	O
the	O
literature	O
[	O
76	O
,	O
77	O
].	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Effect	O
of	O
low	O
temperature	O
incubation	O
on	O
ferritin	B-GP
-	O
protein	O
levels	O
in	O
Caco	O
-	O
2	O
cells	O
following	O
exposure	O
to	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
nano	O
Fe	O
)	O
or	O
Fe	O
(	O
III	O
)	O
maltol	O
(	O
FeM	O
).	O
Cells	O
were	O
incubated	O
for	O
1	O
h	O
in	O
BSS	O
at	O
37	O
°	O
C	O
(	O
closed	O
bars	O
)	O
or	O
4	O
°	O
C	O
(	O
open	O
bars	O
)	O
supplemented	O
with	O
200	O
µM	O
Fe	O
plus	O
a	O
further	O
23	O
h	O
in	O
fresh	O
,	O
non	O
-	O
supplemented	O
MEM	O
to	O
allow	O
for	O
ferritin	B-GP
formation	O
.	O

Data	O
are	O
mean	O
(±	O
s	O
.	O
d	O
.)	O
of	O
3	O
replicate	O
wells	O
within	O
one	O
experiment	O
.	O
**,	O
p	O
=	O
0	O
.	O
001	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

TEM	O
image	O
showing	O
differentiated	O
Caco	O
-	O
2	O
cells	O
incubated	O
at	O
37	O
°	O
C	O
for	O
3	O
h	O
with	O
(	O
A	O
)	O
non	O
-	O
supplemented	O
control	O
media	O
(	O
i	O
.	O
e	O
.	O
balanced	O
salt	O
solution	O
,	O
BSS	O
),	O
(	O
B	O
)	O
control	O
BSS	O
supplemented	O
with	O
maltol	O
alone	O
and	O
(	O
C	O
)	O
BSS	O
supplemented	O
with	O
500	O
µM	O
Fe	O
as	O
the	O
soluble	O
Fe	O
(	O
III	O
)	O
maltol	O
chelate	O
.	O
Scale	O
bar	O
,	O
500	O
nm	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Effect	O
of	O
monensin	O
on	O
cellular	O
protein	O
levels	O
in	O
Caco	O
-	O
2	O
monolayers	O
.	O
Cells	O
were	O
incubated	O
for	O
1	O
h	O
in	O
BSS	O
supplemented	O
with	O
different	O
concentrations	O
of	O
monensin	O
plus	O
a	O
further	O
23	O
h	O
in	O
fresh	O
,	O
non	O
-	O
supplemented	O
MEM	O
.	O

Box	O
and	O
whisker	O
plots	O
show	O
median	O
,	O
minimum	O
and	O
maximum	O
for	O
n	O
=	O
6	O
independent	O
experiments	O
.	O

The	O
red	O
solid	O
line	O
represents	O
the	O
mean	O
cellular	O
protein	O
for	O
all	O
experiments	O
and	O
the	O
dotted	O
red	O
lines	O
represent	O
the	O
corresponding	O
95	O
%	O
confidence	O
interval	O
.	O

No	O
statistical	O
differences	O
were	O
found	O
for	O
any	O
monensin	O
concentration	O
in	O
relation	O
to	O
control	O
cells	O
incubated	O
without	O
monensin	O
(	O
0	O
µM	O
).	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Effect	O
of	O
siRNA	O
targeting	O
of	O
DMT1	B-GP
(	O
closed	O
bars	O
)	O
and	O
Dcyt	B-GP
B	I-GP
(	O
open	O
bars	O
)	O
on	O
iron	O
uptake	O
in	O
HuTu	O
cells	O
.	O
HuTu	O
cells	O
were	O
transfected	O
with	O
siRNAs	O
and	O
,	O
after	O
3	O
days	O
,	O
the	O
cells	O
were	O
incubated	O
for	O
1	O
h	O
in	O
BSS	O
supplemented	O
with	O
10	O
µM	O
Fe	O
as	O
soluble	O
Fe	O
(	O
II	O
)	O
(	O
ferrous	O
sulphate	O
)	O
or	O
LM	O
Fe	O
(	O
III	O
)	O
poly	O
oxo	O
-	O
hydroxide	O
(	O
nano	O
Fe	O
)	O
plus	O
a	O
further	O
23	O
h	O
in	O
fresh	O
,	O
non	O
-	O
supplemented	O
MEM	O
to	O
allow	O
for	O
ferritin	B-GP
formation	O
.	O

Pattern	O
bars	O
indicate	O
scrambled	O
-	O
transfected	O
cells	O
.	O

Data	O
are	O
mean	O
(±	O
s	O
.	O
d	O
.)	O
of	O
3	O
replicate	O
wells	O
within	O
one	O
experiment	O
.	O
****,	O
p	O
<	O
0	O
.	O
0001	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

